Challenges and Countermeasures of Integrative Cancer Therapy in the Epidemic of COVID-19-Reference-Cited by-同舟云学术

Challenges and Countermeasures of Integrative Cancer Therapy in the Epidemic of COVID-19

Published:2020-01 Issue: Volume:19 Page:153473542091281
ISSN:1534-7354
Container-title:Integrative Cancer Therapies
language:en
Short-container-title:Integr Cancer Ther

Author:

Yang Geliang¹^ORCID,Zhang Huiqing²,Yang Yufei³

Affiliation:

1. Department of Traditional Chinese Medicine and Acupuncture, The Second Medical Centre, Chinese People Liberation Army General Hospital, National Clinical Research Center for Geriatric Diseases, Beijing, China

2. Department of Traditional Chinese Medicine, Changhai Hospital, Naval Medical University, Shanghai, China

3. Department of Oncology Diagnosis and Treatment, Xiyuan Hospital of China Academy of Chinese Medical Sciences, Beijing, China

Publisher

SAGE Publications

Subject

Complementary and alternative medicine,Oncology

Link

http://journals.sagepub.com/doi/pdf/10.1177/1534735420912811

Reference2 articles.

1. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

2. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quality of life in hematopoietic stem cell transplantation during the Covid-19 pandemic: case series;O Mundo da Saúde;2024-01-01

2. Calidad de vida y toxicidad financiera de los receptores de trasplantes de células madre hematopoyéticas en COVID-19;Revista Latino-Americana de Enfermagem;2023-12

3. Qualidade de vida e toxicidade financeira dos transplantados de células-tronco hematopoéticas na COVID-19;Revista Latino-Americana de Enfermagem;2023-12

4. Quality of life and financial toxicity of hematopoietic stem cell transplant recipients in COVID-19;Revista Latino-Americana de Enfermagem;2023-12

5. Virtual acupressure for symptom management in cancer populations during COVID-19: a retrospective analysis;Supportive Care in Cancer;2023-04-25